TEVA
Teva Pharmaceutical Industries Ltd.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$41.96
+0.26%Margins
Gross margin
53.5%
EBITDA margin
11.8%
EBIT margin
10.5%
Net margin
2.9%
FCF margin
7.2%
6.3%
Return on equity
1.3%
Return on assets
7.3%
Return on invested capital
0.43x
Asset turnover
$1.8B
Cash from operations
$3.50
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026